News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Anne O’Dea

Articles by Anne O’Dea

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE

BySherene Loi, MD, PhD,Erica Stringer-Reasor,Jean-Sebastien Frenel,Mattea Reinisch,Ruth M. O’Regan,Michelino De Laurentiis,Yeon Hee Park,Anne O’Dea,Yen-Shen Lu,Valeria Gonzalez,Melissa Gao,Sorcha Waters,Huilin Hu,Binghe Xu

June 24th 2025

Latest Updated Articles

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE
Published: June 24th 2025 | Updated:

Trending on CancerNetwork

FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC

ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care

Cognitive Function Improvements Highlighted With Acupuncture Use in Breast Cancer

QOL Improvement in Breast Cancer Noted With YES System

PFS Continues to Improve With Imlunestrant in Advanced Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.